BioMérieux: Information on Share Capital and Voting Rights in September 2026

bioMérieux, a company specializing in in vitro diagnostics, has published a statement regarding its share capital and the number of associated voting rights for September 2026. As of September 30, the share capital amounted to €12,029,370, divided into 118,361,220 shares. Each share of the company, registered under ISIN code FR0013280286, carries a number of voting rights.

The total number of theoretical voting rights is 194,221,480. This figure includes all shares, even those without voting rights. This is a regulatory requirement under Article 223-11 of the General Regulations of the French Financial Markets Authority (AMF). This declaration was made in Marcy l'Etoile, the company's registered office, on October 1, 2026.